Standout Papers

Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome 2021 2026 2022 2024236
  1. Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome (2021)
    Florence Wong, S. Chris Pappas et al. New England Journal of Medicine

Immediate Impact

58 standout
Sub-graph 1 of 21

Citing Papers

Electrospinning and Nanofiber Technology: Fundamentals, Innovations, and Applications
2025 Standout
Acute kidney injury
2025 Standout
2 intermediate papers

Works of Khurram Jamil being referenced

Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome
2021 Standout
Detection of exhaled hydrogen sulphide gas in healthy human volunteers during intravenous administration of sodium sulphide
2010

Author Peers

Author Last Decade Papers Cites
Khurram Jamil 561 370 186 327 49 771
J N Baxter 460 429 169 357 39 906
G. F. Leong 241 195 101 223 40 790
J Chesta 610 510 85 242 28 737
Alexander L. Gerbes 696 448 90 455 22 871
Mortimer Levy 380 245 276 239 77 975
Roger Hallemans 227 161 609 187 35 955
Anthony M. Wheatley 263 246 57 442 44 787
Peter Nissen Bjerring 495 371 70 258 44 973
Leroy Shear 403 279 233 291 36 978
George Dikdan 243 216 76 359 33 823

All Works

Loading papers...

Rankless by CCL
2026